Amgen · 1 day ago
Amgen Science Fellow - Computational Biology, AI, and Advanced Computing
South San Francisco, CA
Full-time
Onsite
New Grad, Entry LevelAmgen is a leading biotechnology company focused on serving patients with serious illnesses. They are seeking an exceptional early-career scientist for the Amgen Science Fellows program to establish an independent research program in computational biology, artificial intelligence, and advanced computing, aimed at advancing drug discovery and therapeutic development.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Establish an independent research program at the intersection of drug discovery, computational biology, artificial intelligence, and emerging computational paradigms, including quantum computing
Support the development and application of advanced computational methods to address foundational challenges in biology, chemistry, and/or therapeutic discovery
Define a forward-looking research agenda that advances computational science as a core driver of next-generation biopharmaceutical R&D
Initiate and manage an independent project with technical support under their direction
Develop a robust research project aimed at breakthrough discoveries and publication
Qualification
Required
Ph.D. in a computational or life sciences discipline with research experience in Computational Biology, AI, and Advanced Computing
Preferred
Demonstrated record of first-author or corresponding-author publications in high-impact journals at the intersection of computation and life sciences
Evidence of independent scientific vision, such as leading a distinct research direction separate from PhD or advisor-driven programs
Experience framing and pursuing long-horizon, high-risk scientific questions rather than incremental method development
Advanced proficiency in modern machine learning architectures (e.g., graph neural networks, foundation models, generative models) applied to biological or chemical data
Strong programming skills with evidence of production-quality code or open-source contributions
Experience working with large-scale, multimodal biological datasets (omics, imaging, molecular, clinical, or simulation-derived)
Familiarity with high-performance computing environments, cloud-based workflows, or scalable model training
Proven ability to integrate data-driven AI approaches with mechanistic, physics-based, or systems-level models
Background in at least one core domain relevant to therapeutic discovery (e.g., structural biology, chemistry, systems biology, pharmacology), beyond purely computational training
Prior exposure to quantum computing, quantum-inspired algorithms, or advanced optimization methods, with demonstrated curiosity about near-term scientific impact
Willingness to prototype and critically evaluate immature or speculative technologies in a rigorous scientific context
Track record of scientific leadership, including mentoring students, coordinating collaborations, or driving cross-disciplinary projects
Strong written and verbal communication skills, with experience presenting complex computational ideas to experimental or translational audiences
Benefits
A comprehensive employee benefits package, including a Retirement and Savings Plan with generous company contributions
Group medical, dental and vision coverage
Life and disability insurance
Flexible spending accounts
A discretionary annual bonus program, or for field sales representatives, a sales-based incentive plan
Stock-based long-term incentives
Award-winning time-off plans
Flexible work models where possible.
Company
Amgen
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Founded in 1980
10001+ employees
H1B Sponsorship
Amgen has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (429)
2024 (485)
2023 (485)
2022 (540)
2021 (460)
2020 (444)
Funding
Current Stage
Public CompanyTotal Funding
$28.5B2022-12-12Post Ipo Debt· $28.5B
1983-06-17IPO
Leadership Team
Robert Bradway
Chairman and Chief Executive Officer
Jay Bradner
Executive Vice President of R&D, and Chief Scientific Officer
Recent News
Pharma Letter
2026-02-07
Labiotech UG
2026-02-07
pharmaphorum
2026-02-06
Company data provided by crunchbase